New drug: dimethyl fumarate to treat psoriasis
Dimethyl fumarate (Skilarence®) was newly registered in 2017 for the treatment of psoriasis. This is not a new drug, as it has been available as an unlicensed product for decades. After the regist ...
Recent articles
Prolonged-release Metformin
Metformin, Glucient® SR (Consilient Health), prolonged-release tablets 500, 750 and 1000 mg
In theory, prolonged-release metformin as a diabetes drug should cause fewer gastro-intestinal adverse ...
Hydrochlorothiazide and skin cancer: a debatable warning?
Dutch care providers and patients were confronted in October 2018 by a nationwide warning about a “slightly increased” risk of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) when usi ...
Ribociclib in breast cancer
Ge-Bu usually discusses new drugs that are going to be frequently used after a recent registration. Hence, one might not expect it to discuss a new drug like ribociclib, as this drug is to be used ...
Acetyl salicylic acid for healthy elderly people?
Medicinal intervention can be an option to help people age in good health and prevent future diseases. This is why the use of low-dose acetylsalicylic acid, which is known for its cardiovascular p ...
Acetylsalicylic acid for patients with diabetes but without cardiovascular disease
Patients with diabetes are at increased risk of cardiovascular disease. One plausible option to prevent these cardiovascular diseases could be the use of acetylsalicylic acid as a primary preventi ...
Omega-3 fatty acids suppletion does not offer cardiovascular benefits
Omega-3 fatty acids, whether from eating fish or as dietary supplements, or produced in the body from alpha linolenic acid of vegetable origin, have always had a favourable reputation in the prev ...
Cardiovascular risks of diclofenac
Side-effects of the use of NSAIDs, such as an increased risk of serious morbidity like gastric haemorrhage and cardiovascular diseases, have been known for years. Recent Danish research shows that ...
